Effect of liver disease in kidney transplant recipients on cyclosporine dose and metabolite levels

Transplant Proc. 1994 Oct;26(5):2655.

Authors

O Alfurayh¹, M Sobh, M Minhas, K Almeshari, K Alshaibani, W Qunibi, H Aesha, S Taher

Affiliation

¹ Section of Nephrology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

PMID: 7940830

No abstract available

Publication types

Clinical Trial
Comparative Study
Controlled Clinical Trial

MeSH terms

Alanine Transaminase / blood
Analysis of Variance
Cyclosporine / adverse effects
Cyclosporine / metabolism
Cyclosporine / therapeutic use*
Female
Follow-Up Studies
Humans
Kidney Transplantation / immunology*
Kidney Transplantation / physiology
Liver Diseases / complications*
Liver Function Tests*
Male
Time Factors

Substances

Cyclosporine
Alanine Transaminase